Published in Neuroscientist on April 01, 2007
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One (2012) 1.59
The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1. Nat Neurosci (2009) 1.43
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol (2009) 1.12
Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow. Epilepsia (2010) 1.10
Identifying targets for preventing epilepsy using systems biology. Neurosci Lett (2011) 1.07
Immune mechanisms in epileptogenesis. Front Cell Neurosci (2013) 1.05
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia (2011) 1.01
Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy. Brain Res (2008) 0.99
Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol (2014) 0.96
Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats. BMC Neurosci (2010) 0.90
Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm (2014) 0.86
Differential changes in mGlu2 and mGlu3 gene expression following pilocarpine-induced status epilepticus: a comparative real-time PCR analysis. Brain Res (2008) 0.83
Base excision repair in physiology and pathology of the central nervous system. Int J Mol Sci (2012) 0.78
Transcriptomic Profiling of Medial Temporal Lobe Epilepsy. J Proteomics Bioinform (2012) 0.78
Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans. BMC Neurosci (2009) 0.76
Kainic Acid Induces mTORC1-Dependent Expression of Elmo1 in Hippocampal Neurons. Mol Neurobiol (2016) 0.75
Blood DNA methylation pattern is altered in mesial temporal lobe epilepsy. Sci Rep (2017) 0.75
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One (2012) 1.59
Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J Neurosci (2002) 1.44
Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci (2003) 1.44
Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia (2004) 1.17
Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia (2010) 1.17
Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia (2006) 1.17
Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation. Epilepsia (2012) 1.15
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia (2005) 1.12
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol (2009) 1.12
Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia (2008) 1.07
COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology (2009) 1.03
Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia (2012) 1.02
Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia (2011) 1.01
Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Res (2010) 0.97
Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia. Epilepsia (2003) 0.96
Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp Neurol (2004) 0.95
Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. J Pharmacol Exp Ther (2009) 0.95
Transient downregulation of Sema3A mRNA in a rat model for temporal lobe epilepsy. A novel molecular event potentially contributing to mossy fiber sprouting. Exp Neurol (2003) 0.95
Blood plasma inflammation markers during epileptogenesis in post-status epilepticus rat model for temporal lobe epilepsy. Epilepsia (2013) 0.92
Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol (2008) 0.92
Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia (2008) 0.91
Dynamics of evoked local field potentials in the hippocampus of epileptic rats with spontaneous seizures. J Neurophysiol (2008) 0.88
Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia (2005) 0.88
Cerebral expression of drug transporters in epilepsy. Adv Drug Deliv Rev (2011) 0.86
Different subsets of newborn granule cells: a possible role in epileptogenesis? Eur J Neurosci (2013) 0.85
Interleukin-1 beta down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes. J Neuroimmunol (2005) 0.85
Presubiculum stimulation in vivo evokes distinct oscillations in superficial and deep entorhinal cortex layers in chronic epileptic rats. J Neurosci (2005) 0.85
Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia (2009) 0.85
GAP-43 mRNA and protein expression in the hippocampal and parahippocampal region during the course of epileptogenesis in rats. Eur J Neurosci (2003) 0.85
Expression of sodium channel α subunits 1.1, 1.2 and 1.6 in rat hippocampus after kainic acid-induced epilepsy. Epilepsy Res (2013) 0.84
Calcium extrusion protein expression in the hippocampal formation of chronic epileptic rats after kainate-induced status epilepticus. Epilepsia (2004) 0.84
Semaphorins: contributors to structural stability of hippocampal networks? Prog Brain Res (2002) 0.82
Overexpression of the human major vault protein in gangliogliomas. Epilepsia (2003) 0.81
Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy. Epilepsia (2011) 0.81
Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats. Epilepsia (2009) 0.80
Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development. Acta Neuropathol (2004) 0.80
Synaptic responses in superficial layers of medial entorhinal cortex from rats with kainate-induced epilepsy. Neurobiol Dis (2007) 0.79
Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β. J Neuroinflammation (2012) 0.79
Physiological changes in chronic epileptic rats are prominent in superficial layers of the medial entorhinal area. Epilepsia (2005) 0.79
Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy. Epilepsia (2004) 0.78
Expression and regulation of voltage-gated sodium channel beta1 subunit protein in human gliosis-associated pathologies. Acta Neuropathol (2003) 0.78
Epilepsy as a dynamic disease of neuronal networks. Handb Clin Neurol (2012) 0.76
Ontogenetic modifications of neuronal excitability during brain maturation: developmental changes of neurotransmitter receptors. Epilepsia (2011) 0.76
Upregulation of neuronal nitric oxide synthase in in vitro stellate astrocytes and in vivo reactive astrocytes after electrically induced status epilepticus. Neurochem Res (2003) 0.76